Jul 26, 2024
Heart Pounding, Stomach-Knotting: Stress & You
The Stress Response Your muscles tense, your heart races and your breath comes faster — we all know what stress feels like. The “fight or flight” response is behind it:…
Resources
Jul 25, 2024
Could Metformin Fill the Bill for Geographic Atrophy Prevention?
Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients by Charles Bankhead, Senior Editor, MedPage TodayJuly 22, 2024 STOCKHOLM — The risk of developing geographic atrophy (GA) declined significantly in…
Jul 8, 2024
FDA approves Vabysmo prefilled syringe for retinal diseases
Key takeaways: The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. The syringe will be available in the U.S. later this year.…
Jul 1, 2024
AI model helps predict anti-VEGF response in diabetic macular edema
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema. Luvisi and…
Jun 25, 2024
Utilizing the immune system to combat dry eye disease
by: Walter O. Whitley OD, MBA, FAAO Exploring strategies for effective management of a multifaceted condition Dry eye disease (DED) is a chronic and often progressive condition that can be…
Jun 25, 2024
Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy
By: David Hutton Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36 months of both continuous monthly and every-other-month treatment. A study…
Jun 11, 2024
FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin
Key takeaways: The Abbott Libre Rio was cleared for adults with type 2 diabetes who do not use insulin. The FDA cleared the Abbott Lingo for adults who want to…
Jun 10, 2024
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)
June 10, 2024 SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting…
Jun 6, 2024
Avirmax Biopharma Inc receives IND approval from FDA
June 6, 2024 by: Martin David Harp The IND approval will allow the company to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular…
Jun 6, 2024
Stealth BioTherapeutics enrols first subject in dry AMD treatment trial
A new dry AMD study. The rate of change in the macular area of photoreceptor loss is the primary efficacy endpoint of ReNEW and ReTAIN trials. Stealth BioTherapeutics has enrolled…
May 30, 2024
FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization
First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients Manassas, VA (May 16, 2024) Digital healthcare provider, Notal Vision,…
May 30, 2024
Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD
May 28, 2024, by; Lynda Charters Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over 3,000 older adults who satisfied the inclusion criteria in the…
May 22, 2024
Press Release
Discover Hope Macular Degeneration Association Connects Patients with Vital Support Macular Degeneration Association offers free resources and events for all SARASOTA, Fla. (May 14, 2024) – The Macular Degeneration Association…
May 12, 2024
Happy Mother’s Day
…
May 3, 2024
16 Ways to Modify Your Home if You Have Diabetic Macular Edema
Low vision can increase your risk of a fall or other mishap. Here’s a room-by-room guide to making your home safer if you have DME. By Maria Masters Medically Reviewed …
May 3, 2024
Study finds link between body weight and retinal thickness
There appears to be a significant association between body weight, specifically preobesity and obesity, and changes in retinal thickness, according to a study that suggests individuals who are preobese, even…
Apr 16, 2024
Treatment challenges in patients with nAMD
by: Lynda Charters David Eichenbaum, MD, discusses his experiences with aflibercept, faricimab. Reviewed by David Eichenbaum, MD David Eichenbaum, MD, from Retina Vitreous Associates of Florida and the Morsani College…
Apr 16, 2024
Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410
by: Sydney M Crago The Phase 1/2 study includes a dose-escalation phase of the study featuring 3 cohorts each one receiving either a low, medium, or high dose of OCU410.…
Apr 15, 2024
New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain
By Lisa Marie Basile | Fact-checked by Davi Sherman -Published March 29, 2024 Key Takeaways New research has drawn a link between vitamin D deficiency (VDD) and diabetic peripheral neuropathy (DPN) in elderly adults with type…
Apr 10, 2024
The Complete Eye Health & Nutrition Guide: Eye Foods
New lower price- The Complete Eye Health & Nutrition Guide: Eye Foods New price $15.00 + $9.95 mailing costs- Limited time Please click here to order your today: https://macularhope.org/shop/y7
Apr 5, 2024
April is Women’s Eye Health and Safety Mont
Did you know that more women suffer from visual impairments than men, per the National Eye Institute? Two-thirds of blindness occur in women according to the World Health Organization. Fortunately,…
Apr 4, 2024
SpyGlass Pharma unveils 1-year data of drug delivery platform implanted during routine cataract surgery in patients diagnosed with glaucoma
by: David Hutton One year after implantation, the enduring IOP reduction remained consistent across all 3 dose strengths.
Apr 3, 2024
ISS National Lab-sponsored study to test a novel gene therapy for AMD
by David Hutton An investigation is set to launch on SpaceX’s 30th Commercial Resupply Services mission to the International Space Station contracted by NASA to test the therapy in space.…
Apr 2, 2024
Beyond the eclipse: The long-term effects of solar retinopathy
by: David Hutton Patients can experience solar retinopathy after viewing the eclipse without protection, but it also can occur from outdoor activities, including those mentioned. It can lead to symptoms…
Apr 1, 2024
Eye safety tips you need to know ahead of the solar eclipse
By: Alex Delaney-Gesing Ahead of the much anticipated solar eclipse on April 8, 2024, experts from across the eyecare space are offering their best clinical advice for how to safely…
Mar 29, 2024
Happy Easter
The Macular Degeneration Association is wishing you and yours a healthy and happy Easter.
Mar 28, 2024
Beacon Therapeutics is Seeking Participants with X-linked Retinitis Pigmentosa
Beacon Therapeutics is Seeking Participants with X-linked Retinitis Pigmentosa Who Have a Mutation (or Defect) in the RPGR Gene for Their Multi-Center, Phase 2/3 Vista Trial To be considered for…
Mar 26, 2024
Topical drop treatment for full-thickness macular hole closure
Wang and colleagues conducted a retrospective case series of patients with full-thickness macular holes. A newly reported study, led by first author Jessie Wang, MD, found that topical therapy resulted…
Mar 21, 2024
The Dangers of Rubbing Itchy Eyes
March 18th, 2024 From scratching your cornea and tearing your retina to introducing allergens and causing infections, pawing at your peepers just doesn’t pay off. Rubbing our eyes: It’s something…
Mar 19, 2024
The Definitive Guide for Macular Degeneration
Welcome to IrisVision’s live webinar, “The Definitive Guide to Macular Degeneration,” an exclusive session aimed at shedding light on one of the most common causes of vision loss among older…